DK161564C - Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase

Info

Publication number
DK161564C
DK161564C DK464483A DK464483A DK161564C DK 161564 C DK161564 C DK 161564C DK 464483 A DK464483 A DK 464483A DK 464483 A DK464483 A DK 464483A DK 161564 C DK161564 C DK 161564C
Authority
DK
Denmark
Prior art keywords
hyaluronidase
preparing
procedure
pharmaceutical preparation
fibrinolytic agent
Prior art date
Application number
DK464483A
Other languages
Danish (da)
English (en)
Other versions
DK464483A (da
DK464483D0 (da
DK161564B (da
Inventor
Francesco Borrelli
Francesco Antonetti
Original Assignee
Farmacologico Serono Spa Istit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmacologico Serono Spa Istit filed Critical Farmacologico Serono Spa Istit
Publication of DK464483D0 publication Critical patent/DK464483D0/da
Publication of DK464483A publication Critical patent/DK464483A/da
Publication of DK161564B publication Critical patent/DK161564B/da
Application granted granted Critical
Publication of DK161564C publication Critical patent/DK161564C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK464483A 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase DK161564C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT49241/82A IT1189379B (it) 1982-10-08 1982-10-08 Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico
IT4924182 1982-10-08

Publications (4)

Publication Number Publication Date
DK464483D0 DK464483D0 (da) 1983-10-07
DK464483A DK464483A (da) 1984-04-09
DK161564B DK161564B (da) 1991-07-22
DK161564C true DK161564C (da) 1992-01-06

Family

ID=11270058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464483A DK161564C (da) 1982-10-08 1983-10-07 Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase

Country Status (12)

Country Link
US (1) US4568543A (it)
EP (1) EP0106812B1 (it)
JP (1) JPS5989630A (it)
AT (1) ATE44467T1 (it)
AU (1) AU559192B2 (it)
CA (1) CA1217717A (it)
DE (2) DE106812T1 (it)
DK (1) DK161564C (it)
ES (1) ES8704736A1 (it)
IL (1) IL69938A (it)
IT (1) IT1189379B (it)
ZA (1) ZA837484B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5279824A (en) * 1988-04-14 1994-01-18 Merck Patent Gmbh Pharmaceutical formulation containing heparin and endo-beta-glucuronidase, useful for the treatment of thrombosis
EP0456724B1 (en) * 1989-01-27 1995-05-03 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
WO1996019221A1 (en) * 1994-12-22 1996-06-27 Smithkline Beecham Corporation Fibrinogen receptor antagonists
AU2003220115A1 (en) * 2002-05-20 2003-12-12 Board Of Regents, The University Of Texas System Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179787A (en) * 1967-03-22 1970-01-28 Biorex Laboratories Ltd Stabilised and Potentiated Therapeutic Enzyme Compositions
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US4271150A (en) * 1979-03-07 1981-06-02 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration

Also Published As

Publication number Publication date
DE106812T1 (de) 1984-08-30
EP0106812B1 (en) 1989-07-12
AU559192B2 (en) 1987-02-26
IT8249241A0 (it) 1982-10-08
EP0106812A3 (en) 1985-09-11
IL69938A (en) 1987-09-16
ES526300A0 (es) 1987-05-01
CA1217717A (en) 1987-02-10
EP0106812A2 (en) 1984-04-25
ES8704736A1 (es) 1987-05-01
US4568543A (en) 1986-02-04
JPS6150927B2 (it) 1986-11-06
AU1988383A (en) 1984-04-12
ZA837484B (en) 1984-06-27
DE3380166D1 (en) 1989-08-17
JPS5989630A (ja) 1984-05-23
DK464483A (da) 1984-04-09
IL69938A0 (en) 1984-01-31
ATE44467T1 (de) 1989-07-15
DK464483D0 (da) 1983-10-07
IT1189379B (it) 1988-02-04
DK161564B (da) 1991-07-22

Similar Documents

Publication Publication Date Title
MY101791A (en) New benzimidazole derivatives
ES8206180A1 (es) Un metodo para producir una composicion farmaceutica solida de un medicamento en microdosis.
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
HUT41718A (en) Process for preparing phenyl-carbamates and pharmaceutical compositions containing such compounds as active substances
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
DK165949C (da) 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
EG18379A (en) Novel pharmacological compounds
DK154537C (da) Hurtig-disintegrerende komprimerede laegemiddelpraeparater
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
DK161564C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende det fibrinolytiske middel urokinase og diffusionsfaktoren hyaluronidase
ES8504127A1 (es) Procedimiento de preparar compuestos 1,4-dihidropiridinicos.
ES8608490A1 (es) Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
PT76247A (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
ES8106498A1 (es) Un procedimiento para la preparacion de derivados del pirrol
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
GB1514113A (en) Therapeutic compositions containing dimercapto-diethyl ether derivatives
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
JO1531B1 (en) New near-compounds

Legal Events

Date Code Title Description
PUP Patent expired